The Akkermansia Company Found to be ‘First to File’ Patent Application to Treat Obesity Through Oral Use of the Probiotic Akkermansia

Decision Rendered by Patent Trial and Appeal Board of USPTO as Company Launches New Probiotic Supplement in U.S. Health Care ChannelMONT-SAINT-GUIBERT, Belgium, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Akkermansia Company, a pioneer in developing “next generation” probiotics and postbiotics, announced today that the Patent Trial and Appeal Board (Board) of the United States Patent and Trademark Office (USPTO) has issued a decision in a patent interference involving the probiotic Akkermansia. In that decision, the Board found that the inventors of applications licensed to The Akkermansia Company — Cani et al. — were the first to file a patent application related to treating a metabolic diso

Also on site :